1235382-40-7

Upstream product

• 65338-95-6 1-(tetrahydropyranyloxy)-2-<(p-tolylsulfonyl)oxy>ethane 
• 95798-23-5 1-(benzyloxycarbonyl)-4-hydroxypiperidine 

Downstream Products

• 1235382-41-8 benzyl 4-(2-hydroxyethoxy)piperidine-1-carboxylate 
• 1235382-44-1 benzyl 4-[2-(tetrahydro-2H-pyran-4-yloxy)ethoxy]piperidine-1-carboxylate 
• 1235382-42-9 benzyl 4-(2-{[(4-methylphenyl)sulfonyl]oxy}ethoxy)piperidine-1-carboxylate 

Relevant academic research and scientific papers

[5,6]HETEROCYCLIC COMPOUND

Abstract: An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof. In the general formula (I), R1 and R2 represent hydrogen atoms, and the like; R3 represents a hydrogen atom, and the like; X, Y, and Z represent nitrogen atoms, and the like; A represents a phenylene group, and the like; n represents 1 or 2, and the like; and V and W represent oxygen atoms, and the like.

CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP

An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof: wherein each substituent is defined as follows: R1 represents an alkyl group or the like; R2 represents an alkyl group or the like; R3 represents a hydrogen atom or the like; and Z represents -CH= or -N=.

CYCLIC COMPOUND HAVING HETERO ATOM

An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof: wherein each substituent is defined as follows: A is a 3- to 10-membered heterocyclyl group and the like, B is an amino group and the like, and X is N and the like.